Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ShaMaran Announces Issuance of Summons to its Bondholders

VANCOUVER, BC, January 12, 2021 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (SNM - TSXV, Nasdaq First North Growth Market) is pleased to announce the issuance today of a Summons for Written Resolution from Nordic Trust AS as Bond Trustee to all Bondholders of the Company’s 12% senior unsecured bonds due 2023 (ISIN: NO 001082645.6) (the “Bonds”) setting out the details of the Proposal (set forth below) with a voting period ending on January 26, 2021. DISCUSSIONS WITH BONDHOLDERS The Company has been in discussions with the informal Ad Hoc Committee representing

Saga Pure Asa: Further Information on Subsequent Offerings – Subscription Period Commences 13 January 2021

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Oslo, 12 January 2021 Reference is made to the stock exchange notices by Saga Pure ASA (the "Company"); on 14 December 2020 regarding a completed private placement of 35,000,000 new shares ("Private Placement I"), (ii) on 21 December 2020 regarding a completed private placement of

SAGA PURE ASA: NÆRMERE INFORMASJON OM REPARASJONSEMISJONER – TEGNINGSPERIODE STARTER 13. JANUAR 2021

IKKE MENT FOR OFFENTLIGGJØRING, PUBLISERING ELLER DISTRIBUSJON, HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I ELLER TIL USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, ELLER ENHVER ANNEN JURISDIKSJON DER OFFENTLIGGJØRINGEN, PUBLISERINGEN ELLER DISTRIBUSJONEN VIL VÆRE ULOVLIG. Oslo, 12. januar 2021 Det vises til børsmeldinger fra Saga Pure ASA ("Selskapet"); (i) den 14. desember 2020 vedrørende en gjennomført rettet emisjon av 35 000 000 nye aksjer ("Rettet Emisjon I"), (ii) den 21. desember 2020 vedrørende en gjennomført rettet emisjon av 30 000 000 nye aksjer ("Rettet Emisjon II"), og (

Tethys Oil’s chairman Geoffrey Turbott declines re-election

The chairman of the Board of Directors of Tethys Oil AB, Geoffrey Turbott, has notified the company and the company’s nomination committee that he will not be available for re-election at the Annual General Meeting in 2021.Geoffrey Turbott joined Tethys Oil’s Board of Directors in 2015 and was elected chairman in 2018. Tethys Oil’s nomination committee has initiated the work to propose a new chairman to the Annual General Meeting of shareholders in 2021.

Cell Impact appoints China Country Manager

Cell Impact (Nasdaq First North Growth Market: CI B) has appointed Mr. Forrest Zhang as Country Manager in China. Mr. Zhang will be based in Shanghai and will begin his new position on May 3, 2021.China is rapidly emerging as one of the key hydrogen fuel cell markets in the world. Eighteen months ago, Cell Impact hired its first full-time employee in China, Mrs. Tingting Guan, with responsibility for identifying and developing attractive project opportunities. By appointing Mr. Zhang as a locally-based Country Manager, Cell Impact is now increasing its reach and impact in this important

#21-10 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

NPRO: Notification regarding TRS-agreement

In connection with expiry of the existing TRS, Carucel Invest AS, a company controlled by Carl Erik Krefting who is a board member of Norwegian Property ASA (NPRO), has on January 12, 2021 entered into a TRS agreement relating to 4 262 801 shares in NPRO. Pursuant to the TRS agreement the exercise price is NOK 13 per share and the termination date is January 14, 2022. Following the transaction Carucel Invest AS will have rights related to 4,262,801 shares through the TRS agreement and will continue to own 356,664 shares, in aggregate equal to 0.71% of the share capital of NPRO. In addition

Magnus Björnum new CFO at Inteno Group

Magnus Björnum has been appointed Chief Financial Officer at Inteno Group AB. Magnus comes from similar positions at companies such as Soft One, GM Financial and Jeeves. “Inteno Group is a company with big ambitions and great potential. The group combines product and software development within the broadband and IoT industry in an atmosphere, where solid business development meets startup”, says Magnus. “Genexis is well established within the European CPE market place with good track records within the growing Fiber to the Home and In-home WiFi segment. IOPSYS is different, a

New small antibodies show promising effects against COVID-19 infection

Researchers at Karolinska Institutet in Sweden have developed, in collaboration with researchers in Germany and the U.S., new small antibodies, also known as nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells. The research study, published in Science, shows that a combined nanobody had a particularly good effect – even if the virus mutated. According to the researchers, the nanobodies have the potential to be developed into a treatment for COVID-19.Specific proteins, spike proteins, on the surface of the SARS-CoV-2 coronavirus help the virus infect host cells.

Coor loses part of IFM contract with Equinor

Coor's agreement with Equinor in Norway consists of delivery of services to production sites, office sites and offshore. After performed tender process, Equinor has decided not to extend the office part of the contract when it expires in October 2021.The contract value for the office sites is approximately SEK 500 M annually. The production sites are not affected by this decision. The offshore part of the agreement was extended in March 2020. For more information, images etc. please visit www.coor.com or contact: Klas Elmberg, CFO and IR-director +46 10 559 65 80 klas.elmberg@

Neste and Avfuel create strategic partnership for sustainable aviation fuel

Neste Corporation, Press Release, 12 January 2021 at 4:10 p.m. (EET) Neste and Avfuel Corporation announce a strategic partnership to create an efficient, continuous supply of sustainable aviation fuel (SAF) in the United States. Neste will provide Avfuel with SAF in volumes able to meet the growing demands of Avfuel’s customers, including fixed base operators (FBOs), airports, flight departments, original equipment manufacturers (OEMs) and commercial operators. Avfuel will be a branded SAF distributor for Neste, and will sell it under the brand name Neste MY Sustainable

Invitation to Electrolux Q4 presentation

Electrolux results for the fourth quarter of 2020 will be published on February 2, 2021, at approximately 08.00 CET.A telephone conference will be held following the release of the results, starting at 09.00 CET. Jonas Samuelson, President and CEO and Therese Friberg, CFO will comment on the report. Slides used in the presentation will be available at Electrolux website, www.electroluxgroup.com/ir. The fourth quarter report will also be available at the same address. You can listen to the presentation here . The details for

WorkWave Wins Gold in 10th Annual Best in Biz Awards

WorkWave Payments recognized as Best New Product of the Year – SMB for its integrated payment processing solutionHolmdel, N.J., - January 12, 2021 - WorkWave , a leading provider of cloud-based software solutions that support every stage of a service business’s life cycle, today announces that its integrated payment processing solution, WorkWave® Payments , has been awarded Gold for Best New Product of the Year – SMB in Best in Biz Awards , the only independent business awards program judged

BNP PARIBAS HIRES SOFIA LÖNNQVIST FOR CAPITAL MARKETS NORDIC DIVISION

BNP Paribas continues to invest in the Nordic region with an appointment to further strengthening its leading position in Debt Capital Markets.Sofia Lönnqvist joins BNP Paribas Northern European Debt Capital Markets (DCM) Origination Team for Financial Institutions. She will be responsible for the Nordic region linking to our distribution and underwriting platform globally.   Sofia joins after 8 years at Barclays where she worked in DCM Nordics. She has experience in Rating Advisory and Investor relations at Barclays as well as working at UBS and Bank of America Merrill Lynch. Sofia will

Get your VPN questions answered

VPN A2Z (vpna2z.com) is a new service for everyone that needs internet access from a different geolocation than where they are."What is the purpose of using VPN?", "Which Browsers Have Built-In VPN?" or "Is it safe to do a bank transaction while connected to a VPN?". VPN A2Z  is the new place where they try to answer every question related to VPNs, as the questions above.  "It is our goal to make the absolute best resource online. Especially focussing on all the small and maybe a little weird questions, that people might have regarding VPNs" says Francky who is one of

Intervacc Announces Submission of Responses to EMA Day 120 Questions

Stockholm, January 12, 2021 - Intervacc AB (publ) announces that the responses to the Day 120 questions regarding the Company’s Marketing Authorization Application (MAA) for Strangvac has been submitted today to the European Medicines Agency (EMA). Intervacc is seeking approval for Strangvac as a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally. After validating the submission and reviewing the responses, a second list of questions and outstanding issues is expected from the Committee for Medicinal Products for Veterinary Use (CVMP).

Aspire Global Expands Partnership with 888casino to Portugal

Aspire Global’s Pariplay has signed a partnership for games with 888 Holdings, covering Portugal. The partnership expands 888casino and Pariplay’s existing relationship, which has already seen 888 offer exciting titles by Pariplay for its UK, Romanian and Italian customers.On 26 November 2020, Aspire Global announced that Pariplay, a leading game studio and game aggregator, will be going live in the Spanish market with 888casino, a multi-award-winning online casino. Now players also in Portugal can enjoy Pariplay’s much loved titles including Wolf Riches, Mystic Manor, Rumble Rhino and

European Directories announces intra-group transaction of Herold by dogado

European Directories announces that its majority-owned subsidiary dogado GmbH will acquire the share capital of fully owned Austrian group company, Herold Business Data GmbH (“HEROLD”). The transaction results in the establishment of a leading provider offering the most comprehensive range of website and online marketing services for small and medium-sized businesses in Austria. Closing of the transaction is expected in February. The unification of HEROLD and dogado group creates a player with a unique strategic position in the digital market: both companies specialize in supporting

BioStock: Saniona's CEO on the plans for 2021

Saniona has an ambitious plan for 2021, including advancement of its primary drug candidate Tesomet, which targets the rare diseases hypothalamic obesity (HO) and Prader-Willi syndrome (PWS). Saniona’s US-based CEO Rami Levin talked to BioStock about the plans for the year, including the intention to start Phase IIb studies in both HO and PWS during the first half of the year.Read the full interview with Rami Levin at biostock.se: https://www.biostock.se/en/sanionas-ceo-on-the-plans-for-2021/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.

Bulletin from the Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ)

12 January 2021 – The Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) was held on 12 January 2021 at the offices of Setterwalls Advokatbyrå at Sturegatan 10, Stockholm. Attendance at the meeting was solely possible via postal voting. The following resolutions were passed at the general meeting.Resolution to amend the articles of associationThe general meeting resolved, in accordance with the board of director’s proposal, to amend the Company’s articles of association with respect to, inter alia, prerequisites for participation at general meetings, the limits for

Alma Media issues positive profit warning following better than anticipated profitability development in Q4

Alma Media Corporation                                         Inside information 12 January 2021 at 1.20 p.m.ALMA MEDIA ISSUES POSITIVE PROFIT WARNING FOLLOWING BETTER THAN ANTICIPATED PROFITABILITY DEVELOPMENT IN Q4 Alma Media raises its guidance for the 2020 adjusted operating profit for continuing operations. The adjusted operating profit for Q4 2020 falls short of the level of the comparison period, while fall in profitability is less than anticipated in 2020. The company expects that the adjusted operating profit for 2020 will decline less than 10 per cent of the comparison

BioStock: Ultimovacs announces collaboration with AstraZeneca

Ultimovacs announced this morning that it will be participating in a phase II study in collaboration with AstraZeneca, along with the Nordic Society of Gynaecological Oncology (NSGO) and the European Network of Gynaecological Oncological Trial Groups (ENGOT). The aim of the randomized clinical trial is to evaluate Ultimovacs' proprietary universal cancer vaccine, UV1, in combination with AstraZeneca's durvalumab and olaparib in patients with relapsed ovarian cancer.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-announces-collaboration-with-astrazeneca/

Strong preclinical immunization data for the ABNCoV2 cVLP-based COVID-19 vaccine published in Nature Communications

Today, ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces the publication of strong virus neutralization properties in animal proof-of-concept data for ABNCoV2, a unique capsid virus like particle (cVLP) based COVID-19 vaccine coated with ExpreS2-made SARS-CoV-2 antigens, in the esteemed scientific journal Nature Communications. The ABNCoV2 COVID-19 vaccine is the result of a strong collaboration effort by ExpreS2ion and its joint venture partner AdaptVac ApS (“AdaptVac”) together with the PREVENT-nCoV consortium, with an exclusive global

There are no items matching the current filter
There are no more items matching the current filter
Back to top